Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P03999
UPID:
OPSB_HUMAN
Alternative names:
Blue cone photoreceptor pigment; Blue-sensitive opsin
Alternative UPACC:
P03999; Q13877
Background:
Short-wave-sensitive opsin 1, also known as Blue cone photoreceptor pigment or Blue-sensitive opsin, plays a pivotal role in vision. It is a visual pigment molecule essential for absorbing light and mediating vision, primarily in the blue spectrum. This protein is integral to the maintenance of cone outer segment organization in the ventral retina and ensures the correct abundance and localization of retinal membrane proteins, potentially enhancing spectral sensitivity in low light conditions.
Therapeutic significance:
The association of Short-wave-sensitive opsin 1 with Tritan color blindness, a disorder characterized by a selective deficiency of blue spectral sensitivity, underscores its clinical importance. Understanding the role of Short-wave-sensitive opsin 1 could open doors to potential therapeutic strategies for vision disorders, particularly those affecting color perception.